Purchases and Sales Made in Q2 2025 in Enanta Pharmaceuticals Inc (ENTA)
This table provides information about the institutional ownership of Enanta Pharmaceuticals Inc (ENTA) during Q2 2025. The information is specifically focused on institutions that hold shares of ENANTA PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 10, 2025
Q2 2025
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
11.1KNew |
$47.3K - $88.3K
|
11.1K
$77.3K
|
|
|
Jul 11, 2025
Q2 2025
|
Farther Finance Advisors, LLC
San Francisco, CA |
BUY
|
- |
5.78K+ 11558.0% |
$24.6K - $45.9K
|
5.83K
$40.6K
|
|
|
Jul 07, 2025
Q2 2025
|
Versant Capital Management, Inc
|
BUY
|
- |
1.42KNew |
$6.07K - $11.3K
|
1.42K
$9.91K
|
|
|
Jul 14, 2025
Q2 2025
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-762- 57.64% |
$3.25K - $6.06K
|
560
$3.9K
|
|
|
Jul 11, 2025
Q2 2025
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-6.29K- 5.58% |
$26.8K - $50K
|
106K
$740K
|